Msa 815184 Gmi Iodine P100 Cartridge Review

Is the MSA 815184 GMI the right iodine-vapor cartridge for nuclear medicine and reactor maintenance?

Published June 10, 2026 · Last updated July 27, 2026

Short answer: Yes — if your exposure profile includes elemental iodine (I₂) or methyl iodide (CH₃I) in a nuclear medicine, radiopharmacy, or nuclear power plant maintenance environment, the MSA GMI is the Comfo-platform solution with an integrated P100 stage for simultaneous particulate protection. It is purpose-engineered for radioiodine respiratory protection and has no direct cross-brand equivalent in its specific iodine-plus-P100 formulation. Snap-on Advantage platform users should evaluate the MSA Advantage GMI instead.

Published to MSA respirator filters and cartridges · /blogs/product-reviews/msa-815184-gmi-iodine-p100-cartridge-review

The MSA 815184 GMI occupies a specialized niche that very few cartridges on the market address: combined elemental iodine vapor (I₂) and methyl iodide (CH₃I) protection with an integrated P100 particulate stage, on the MSA Comfo bayonet platform. Nuclear medicine technologists, radiopharmacists, and nuclear power plant maintenance crews are the primary users — a population that requires documented NIOSH-approved respiratory protection for radioiodine exposure, not general industrial gas cartridges.

This review covers the GMI's protection chemistry, platform compatibility, application boundaries, and how it fits against its closest site alternatives — the Advantage GMI for snap-on users, and the MSA MERSORB for the mercury/chlorine market that sometimes appears in the same facility. One important clinical framing note: the GMI prevents respiratory uptake of radioiodine — it does not replace potassium iodide (KI) thyroid-blocking tablets, which address thyroid dose from residual body burden via a different mechanism entirely.

Who the MSA 815184 GMI is for

• Nuclear medicine technologists — handling I-131 in therapy dose preparation, diagnostic imaging, and laboratory processing
• Radiopharmacists — compounding or dispensing radioiodine-labeled pharmaceuticals in nuclear pharmacy settings
• Nuclear power plant maintenance crews — reactor coolant system work and fuel handling where elemental iodine release is a credible exposure scenario
• Nuclear medicine preparation labs — research facilities synthesizing radioiodinated tracers or antibodies
• Thyroid cancer treatment facilities — clinical staff involved in high-dose I-131 administration and patient handling during treatment isolation
• Any industrial hygiene program that has documented airborne radioiodine exposure potential and specifies an iodine-specific NIOSH-approved cartridge

For Advantage snap-on platform users in the same environments, the MSA Advantage GMI provides equivalent iodine + P100 coverage on the snap-on mount. Browse the full MSA respirator filters and cartridges collection to compare platform options.

What the MSA GMI does well

Dual iodine chemistry — I₂ and CH₃I in one cartridge

Radioiodine exposure in nuclear environments occurs in two primary chemical forms: elemental iodine (I₂), a volatile solid that sublimates at room temperature, and methyl iodide (CH₃I), an organic iodide produced during fission and used as a tracer compound. These two forms have different physical and chemical properties — I₂ is relatively large and polar; CH₃I is small and less polar — requiring a sorbent formulation that captures both. The GMI's impregnated activated carbon bed addresses both forms in a single cartridge, eliminating the need for stacking separate I₂ and CH₃I cartridges in mixed-exposure environments.

Integrated P100 stage — no separate filter required

The GMI combines the iodine sorbent bed with a NIOSH-rated P100 particulate filter (≥99.97% efficiency) in one assembly. This matters practically: nuclear medicine and reactor environments often generate both aerosols (radioactive particles from liquid spills, aerosol generators, or contaminated surfaces) and vapor-phase iodine simultaneously. A gas-only cartridge without P100 would require a separate stacked filter, adding bulk, breathing resistance, and a second change-out schedule to track. The integrated design simplifies the program and the maintenance burden. Compare this to the MSA GME, which has no particulate stage, or the MSA GMT, which also requires a separate P100 filter stacked over it for combined protection.

Primary use case for the Ultra-Elite at APF 50

The GMI is predominantly deployed with the MSA Ultra-Elite full-face respirator, which delivers APF 50. In nuclear medicine facilities, airborne I-131 concentrations during therapy dose preparation or patient handling can be multiples of the derived air concentration (DAC) limit, requiring the full APF 50 protection factor. Half-mask Comfo facepieces (APF 10) may be adequate for lower-exposure monitoring tasks, but high-activity handling typically requires full-face protection. The program's RSO and CIH define the required APF based on measured or modeled air concentrations for each task.

No direct cross-brand equivalent on the Comfo mount

This is a genuine market gap, not a marketing claim. The 3M and Moldex product lines do not offer an iodine-specific vapor cartridge with integrated P100 on the Comfo bayonet platform. Cross-brand mixing (3M cartridge on MSA facepiece or vice versa) is prohibited under the NIOSH approval framework — a NIOSH approval is granted to a specific facepiece/cartridge combination, not to the cartridge alone. Facilities using MSA Comfo facepieces for their nuclear medicine respiratory protection program have the GMI as their only NIOSH-approved iodine option on that platform.

NIOSH 42 CFR Part 84 approval

The GMI carries NIOSH approval under 42 CFR Part 84, independently verifiable on the NIOSH Certified Equipment List (CEL). For NRC-regulated facilities (nuclear power plants, nuclear pharmacies), NIOSH-approved respiratory protection equipment is a regulatory baseline requirement under 10 CFR Part 20 (radiation protection) as well as OSHA 29 CFR 1910.134. Unapproved or non-NIOSH-tested cartridges do not satisfy either standard.

Where the MSA GMI falls short

Does not protect against acid gases, inorganic gases, or organic vapors

The GMI's sorbent bed is formulated specifically for iodine compounds. It provides no protection against the broad inorganic gas matrix covered by the GME (Cl₂, HF, SO₂, H₂S, NH₃, etc.), the acid gases covered by the GMB, or organic vapors covered by the GMA. Nuclear facilities with co-existing chemical hazards — maintenance work in areas where acid cleaning or organic solvent use occurs simultaneously with radioiodine potential — require a separate cartridge selection process. A single GMI does not cover mixed chemical + radioiodine scenarios.

No ESLI — change-out schedule is mandatory

The MSA GMI has no end-of-service-life indicator. Iodine breakthrough at low concentrations may not be detectable by odor at harmful concentrations — particularly for I-131, where the radiological hazard (absorbed dose to the thyroid) is the concern rather than acute chemical toxicity. Relying on smell or taste as breakthrough indicators is not a compliant change-out strategy under OSHA 29 CFR 1910.134. The written respirator program must specify an objective change-out schedule based on measured air concentrations and manufacturer service-life data.

Does not replace potassium iodide (KI) thyroid blocking

This is the most important clinical boundary to state accurately. The GMI prevents inhalation exposure to radioiodine — it reduces the dose delivered to the thyroid via the respiratory route. It does not address thyroid dose from radioiodine already absorbed into the body, radioiodine ingested through contaminated food or water, or dose from external photon irradiation. Potassium iodide (KI) saturates the thyroid to block uptake of radioiodine regardless of the entry route — it operates via a completely different mechanism. In a nuclear emergency or high-activity spill scenario, both GMI respirator protection and KI administration may be indicated; they are complementary, not interchangeable. The facility's radiation safety officer (RSO) and emergency response plan govern KI distribution protocols.

Comfo bayonet only — Advantage users need a different SKU

The GMI uses the Comfo GM-series bayonet mount. It is physically incompatible with the snap-on mount of the MSA Advantage 200, 290, 420, 1000, and 3000 series — the most widely used MSA half-mask in non-nuclear industrial settings. Facilities running mixed fleets (Comfo for full-face nuclear work, Advantage for routine maintenance half-mask use) must stock both GMI (Comfo bayonet) and Advantage GMI (snap-on) to cover both facepiece types.

MSA GMI vs. the competitive set

3M does not offer a direct iodine-specific (I₂ + CH₃I) vapor cartridge with P100 on the Comfo bayonet platform. Facilities locked to MSA Comfo facepieces have the GMI as their only NIOSH-approved iodine cartridge option for that mount. Cross-brand mixing is not permitted under the NIOSH approval framework.

MSA Advantage GMI on Amazon MSA MERSORB on Amazon

Common questions

What does the MSA 815184 GMI cartridge protect against?

The MSA GMI protects against elemental iodine vapor (I₂), methyl iodide (CH₃I), and airborne particulates at P100 efficiency (≥99.97%). It does not protect against acid gases, organic vapors, inorganic multi-gas hazards (Cl₂, SO₂, HF, H₂S), mercury vapor, tritium, carbon monoxide, or oxygen-deficient atmospheres. Its application is specifically nuclear medicine, radiopharmacy, and nuclear power plant radioiodine environments.

MSA GMI vs. MSA Advantage GMI — which one do I need?

The choice is determined entirely by your facepiece platform. The MSA 815184 GMI uses the Comfo GM-series bayonet mount — compatible with Comfo Classic, Comfo II, Advantage 200 LS, Ultra-Twin, and Ultra-Elite. The MSA Advantage GMI (815641) uses the snap-on mount for Advantage 200, 290, 420, 1000, and 3000 series. The iodine protection chemistry is equivalent; the mount is not interchangeable. Check your facepiece model before ordering.

Does the MSA GMI protect against radioactive iodine (I-131)?

The GMI captures the chemical forms of iodine it is rated for — elemental iodine (I₂) and methyl iodide (CH₃I) — including their radioactive isotope variants (I-131 in those chemical forms). It prevents the inhalation route of radioiodine exposure. It does not block external gamma/beta radiation from I-131, and it does not replace thyroid-blocking potassium iodide (KI) for preventing thyroid uptake from iodine already absorbed systemically. Consult your facility's RSO for a complete radioiodine protection plan that addresses all exposure pathways.

Does the GMI replace potassium iodide (KI) thyroid protection?

No. The GMI and KI address different exposure mechanisms and are complementary, not interchangeable. The GMI prevents inhalation uptake of radioiodine through the respiratory tract. KI saturates the thyroid to block uptake of radioiodine regardless of entry route — ingestion, inhalation of residual body burden, or skin absorption. In a high-activity spill scenario or emergency involving radioiodine release, both a respirator with GMI cartridges and KI administration may be indicated. KI distribution is governed by the facility's RSO and emergency response plan, not the respiratory protection program alone.

Is the MSA GMI NIOSH approved?

Yes. The MSA 815184 GMI is approved under NIOSH 42 CFR Part 84. Verify the approval independently on the NIOSH Certified Equipment List (CEL). For NRC-regulated nuclear medicine and nuclear power facilities, NIOSH-approved respiratory protection is a regulatory baseline under both 10 CFR Part 20 and OSHA 29 CFR 1910.134. Non-NIOSH-approved iodine cartridges do not satisfy program requirements.

What facepieces are compatible with the MSA 815184 GMI?

The GMI uses the Comfo GM-series bayonet mount and is compatible with MSA Comfo Classic, Comfo II, Advantage 200 LS, Ultra-Twin, and Ultra-Elite. It is not compatible with MSA Advantage snap-on facepieces (200, 290, 420, 1000, 3000) or any 3M or Moldex facepiece.

What protection factor does the GMI system provide?

The assigned protection factor (APF) is determined by the facepiece, not the cartridge. The MSA Ultra-Elite and Ultra-Twin full-face facepieces paired with the GMI deliver APF 50 — allowing use at up to 50x the applicable TLV or PEL. Half-mask Comfo facepieces (Comfo Classic, Comfo II, Advantage 200 LS) deliver APF 10. For nuclear medicine dose preparation and high-activity reactor tasks, APF 50 is typically the minimum required; the written program's CIH and RSO define the required APF by task and measured concentration.

Does the MSA GMI have an end-of-service-life indicator (ESLI)?

No. The GMI has no ESLI. Iodine compounds — especially at the low concentrations encountered in nuclear medicine preparation — may not provide reliable odor warning before breakthrough. OSHA 29 CFR 1910.134 Appendix B requires a documented change-out schedule based on objective data when no ESLI is present. Consult the MSA Technical Data Sheet and your CIH or RSO to develop a compliant schedule for your specific air concentration data.

MSA GMI vs. MSA MERSORB — what is the difference?

The MERSORB (815185) uses MERSORB sorbent technology designed specifically for elemental mercury vapor (Hg⁰) and chlorine (Cl₂) — it is the correct choice for chlor-alkali workers, dental professionals, and mercury recovery operations. The GMI is designed for iodine vapor (I₂ and CH₃I). They address entirely different chemical hazards, and one cannot substitute for the other. See the MERSORB review for the full mercury vapor program analysis.

Can I use the GMI for general hospital or pharmacy environments without a nuclear medicine program?

The GMI is not a general-purpose hospital or pharmacy cartridge — it is engineered for iodine vapor specifically. Standard hospital and compounding pharmacy environments typically involve different vapor hazards (formaldehyde, glutaraldehyde, isoflurane, organic solvents) better addressed by OV or OV/acid gas cartridges. Unless your facility's IH assessment documents airborne I₂ or CH₃I as a credible exposure — which typically means an active nuclear medicine or radiopharmacy program — a different cartridge is the appropriate specification.

What is the per-cartridge cost for the MSA 815184 GMI?

The MSA 815184 GMI sells in a standard box of 6 cartridges at the listed price, making the per-cartridge cost the listed price. This is competitive for a specialty nuclear-grade iodine cartridge with integrated P100 filtration. For comparison, the MERSORB (mercury/chlorine/P100) is the listed price per cartridge, while the Low-Profile P100 filter (particulate only) is the listed price per filter. Check current Amazon pricing.

Is there a 3M equivalent to the MSA GMI?

3M does not offer a direct equivalent to the MSA GMI in an iodine-specific (I₂ + CH₃I) vapor cartridge with integrated P100 on the Comfo bayonet mount. Even if a cross-brand iodine cartridge existed, cross-brand mixing — using a 3M cartridge on an MSA facepiece or vice versa — is not permitted under the NIOSH approval framework, which approves the facepiece/cartridge combination as a system. Facilities using MSA Comfo facepieces have the GMI as their only NIOSH-approved iodine cartridge option on that platform.

How many cartridges come in a box of MSA 815184 GMI?

The standard packaging for the MSA 815184 GMI is a box of 6 cartridges (the listed price per box, the listed price per cartridge). Note that respiratory cartridges are used in pairs — one on each side of a full-face or dual-cartridge half-mask facepiece — so a box of 6 provides 3 complete cartridge pairs (3 shifts at end-of-shift change-out for a single user).

Can the GMI be stacked with additional filters?

The GMI already includes an integrated P100 particulate stage, so additional P100 stacking is not necessary or recommended unless specifically directed by the manufacturer's instructions. In environments requiring supplemental protection beyond the GMI's iodine + P100 coverage — such as concurrent acid gas hazards — consult the MSA Technical Data Sheet and your CIH for a cartridge combination strategy, as the GMI's integrated design may limit stacking options compared to a bare gas cartridge like the GME.

Does the MSA GMI protect against both elemental iodine and methyl iodide?

Yes. The GMI's sorbent formulation is specifically designed to capture both elemental iodine (I₂), a volatile solid that sublimates at room temperature, and methyl iodide (CH₃I), an organic iodide with distinct chemical properties from I₂. This dual-form coverage is critical in reactor and nuclear medicine environments where both forms may be present. A cartridge rated for I₂ alone would have inadequate protection against CH₃I in mixed-iodine environments.

Sources. Requirements referenced here come from OSHA 29 CFR 1910 and the NIOSH recommendations. Where a consensus standard governs, the ANSI document is named in the text.

Related reference

Neighbouring references on this site: honeywell north 5500 vs msa advantage 1000: cross-brand silicone vs, how to choose a respirator cartridge: complete selection guide, which msa respirator platform is right for you?, msa gmc-p100 vs 3m 60923: ov/acid gas/p100 cartridge comparison, msa vs 3m respirator cartridges: complete brand comparison, and 3m secure click respirator filters cartridges guide 2026.

Why trust WC Safety

WC Safety is an independent, affiliate-supported review site. It is not a retailer: it holds no inventory, takes no orders, and earns only from qualifying purchases through clearly marked links — which never changes what a product is rated to do. Standards language is taken from the regulation text directly, and ratings are reported as the manufacturer publishes them. We run no laboratory and perform no testing of our own. Where published sources disagree, we say so and plan on the conservative figure rather than the flattering one.

Our methodology

Figures come from the regulation and the published specification, in that order. Derated numbers are calculated, not estimated. Nothing here is presented as a measured result, because we measure nothing.

Researched and written by Steven Eaton, editor of WC Safety. Steven holds no safety certification and does not test products; this page compares what manufacturers and regulators publish, with the gaps in that record marked. Last reviewed August 2026.